Preview

Medical Herald of the South of Russia

Advanced search

SOME THROMBOCYTE FACTORS DEVELOPMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C

https://doi.org/10.21886/2219-8075-2013-1-46-50

Abstract

Purpose: to examine the frequency of mutations W 515K and W 515L in the Mpl, the encoder receptors platelets to thrombopoietin and determine the degree of activity of enzymes of blood platelets - glycogen, alpha-naphthylhesterase(αANАE) and adenosine triphosphatase (ATPase). at patients with chronic active liver disease.

Materials and methods. The RT PCR was used for research mutations in Mpl (W 515K and Mpl W 515L),to determine the degree of activity of enzymes studied the strokes of the peripheral blood.

Results: HCV-infected patients of both groups have demonstrated more high frequency of strong mutation in W515L than in healthy people. The same trend had been observed in regards to mutation in W515K. In the group of CHC patients with thrombocytopenia level of glycogen was lower and activity of αANАE was higher than in the group of patients without thrombocytopenia. Essential difference of ATPase activity in both groups was not established.

Summary. Expressed point mutations in platelet thrombopoietin receptors and the identified violations of the enzymatic activity of platelets, may serve as prognostic aggravate factors of the course of CHC. 

About the Authors

N. Y. Pshenichnaya
Rostov State Medical University
Russian Federation

Department of Infectious Diseases with Pediatric Infectious Diseases and Epidemiology Courses in the Postgraduate Faculty

29 Nakhichevansky st., Rostov-on-Don, 344022


G. V. Kuznetsova
Rostov State Medical University
Russian Federation

Department of Infectious Diseases with Pediatric Infectious Diseases and Epidemiology Courses in the Postgraduate Faculty

29 Nakhichevansky st., Rostov-on-Don, 344022


References

1. Andrew I. Schafer Thrombocytosis/I.Andrew Schafer // N Engl J Med.- 2004.-№3.-Р.1211.

2. Fujii H. Life-threatening severe immune thrombocytopenia during alpha-interferon therapy for chronic hepatitis C/H.Fujii, T.Kitada, T.Yamada , et al. // Hepatogastroenterology.- 2002.-№ 50.-Р. 841- 842.

3. Passamonti F. Clinical relevance of JAK2 (V617F) mutant allele burden./F. Passamonti, E.Rumi // Haematologica. -2009.- Vol.9, №1.-Р. 7-10.

4. Соколова Н. А. Изменения в представлении о патогенезе Ph-негативных миелопролиферативных заболеваний / Н. А. Соколова, М. И. Савина // Молодой ученый. - 2011. - №5.- Т.2. - С. 216-219.

5. Волков М.А. Клиническая онкогематология./ М.А. Волков // 2001 г.- С.234-243

6. Marjorie B. Zucker, Jennie Borrelli A survey of some platelet enzymes and functions: the plateleta as the source of normal serum acid glycerophosphatase / B.Marjorie , Zucker, Jennie Borrelli // Annals of the New York Academy of Sciences. Enzymes in Blood – 1958. –Р. 203–213.

7. Шитикова А. С. Тромбоцитарный гемостаз. / А.С.Шитикова//— 2000г.С. 101-135.

8. Бурячковская Л. И. Гетерогенность тромбоцитов человека и животных. Связь морфологических особенностей с функциональным состоянием: Автореф. дис. д-ра биол. наук. — М., 2007г.-С.116-156.

9. AnttinenН., Tuderman L., Oikarinen A. Kivirikko K.I. Intracellular enzymes of collagen biosynthesis in human platelets / H.Anttinen, L. Tuderman, A. Oikarinen ,K.I. Kivirikko // Blood. – 1977.- Vol. 50, № 1.- P. 29-37.

10. Лойда 3., Госсрау Р., Шиблер Т. Гистохимия ферментов./ Москва, Мир, 1982.-С.106-107.


Review

For citations:


Pshenichnaya N.Y., Kuznetsova G.V. SOME THROMBOCYTE FACTORS DEVELOPMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C. Medical Herald of the South of Russia. 2013;(1):46-50. (In Russ.) https://doi.org/10.21886/2219-8075-2013-1-46-50

Views: 493


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2219-8075 (Print)
ISSN 2618-7876 (Online)